Background

BRCA1 and BRCA2 are tumor suppressor genes that play a crucial role in DNA repair. Mutations in these genes have been linked to an increased risk of breast and ovarian cancer. The identification of compounds that can bind to these genes and enhance their function has the potential to lead to new therapies for these types of cancers. Our team was tasked with conducting a comprehensive screening and analysis of compounds to identify a lead compound with high potential for binding and docking.

Problem

The challenge was to identify a compound that could effectively bind to BRCA1 and BRCA2, enhancing their function as tumor suppressors. The search for such compounds is time-consuming and expensive, making it difficult to conduct experimental studies on a large scale. Additionally, the complexity of the molecular structure of these genes makes it challenging to design effective drugs without extensive computational modeling.

Solution

We utilized chemsketch software to design new structures based on identified subfragments to enhance the lead compound’s potential. We then performed in Silico molecular docking studies and pharmacophore analysis of phytochemicals against BRCA1 and BRCA2 using AutoDock Vina software. This allowed us to evaluate the potential of various phytochemicals as therapeutic agents without having to conduct experimental studies on each individual compound.

Impact

Identified several phytochemicals with high potential for binding and docking with BRCA1 and BRCA2
Demonstrated the effectiveness of in Silico screening methods for identifying potential drug candidates
Laid the groundwork for further experimental studies on identified compounds
Potential impact on breast and ovarian cancer treatment through the development of new therapies

Team

John Smith - Computational Chemist
- Designed new structures based on identified subfragments using chemsketch software
- Conducted in Silico molecular docking studies and pharmacophore analysis of phytochemicals against BRCA1 and BRCA2 using AutoDock Vina software
Maria Rodriguez - Biomedical Engineer
- Analyzed the results of the molecular docking studies and pharmacophore analysis to identify potential drug candidates
- Liaised with experimental teams to plan further studies on identified compounds
Samantha Lee - Data Analyst
- Cleaned and processed large datasets for use in the computational modeling studies
- Analyzed the results of the computational modeling studies to identify trends and patterns in the data

Identifying Phytochemicals for Cancer Therapy